The MAHA Movement Reshapes School Cafeterias Rising Costs and Policy Shifts Ahead Dragonfly DFLI Q1 2026 Earnings Miss Sparks Concern Yardeni Warns Fed Chair Warsh May Face Pressure to Raise Rates in July as Bond Vigilantes Flex Live Oak LOB Q1 2026 Beat Revenue NA EPS Exceeds by Significant Semiconductor Stocks Extend Recent Recovery as Nvidia Earnings Approach SelfStorage Operators in Vermont Report Surging Demand Amid Housing Crunch and Aging Demographics Chemists and Druggists Stage Peaceful Nationwide Strike Urge PMs Intervention on Online Medicine Sales Yimutian YMT Stock Today Drops 1313 Critical Support Levels 20260521 Fox Corporation FOXA Shares Decline in Q1 After Strong Prior Performance HF Sinclair Corp Subject of New Analyst Report from Yahoo Finance Surging Gasoline Costs Force Americans to Tap Emergency Savings ATTs BlueCollar Hunt Highlights AI Economys Workforce Shift Krispy Kreme Data Breach Settlement Deadline Approaches 16M Claims Due June 22 SEC Delays Regulatory Exemptions for Tokenized Stock Trading by Crypto Firms PRU Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment Despite Modest Stock Dip Ellington Credit Company EARN Q2 2025 Earnings EPS Misses Estimates as Credit Market Challenges Persist Dingdong DDL Q4 2025 Earnings Positive EPS Performance Amidst Sparse Data Alaunos Therapeutics TCRT Q4 2023 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Exodus Movement Inc EXOD Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Data Unavailable EU Member States Endorse EUUS Trade Deal Setting Stage for Final Approval Gokaldas Exports Q4 Net Profit Declines 3197 Amid Revenue Growth Polymarket Opens Retail Access to Prediction Contracts on OpenAI and SpaceX Chinese EVs Depreciate Faster Than Rivals in German Market Report Says Arabica Coffee Prices Soar to Record High Amid USColombia Tariff Dispute SpaceX Successfully Launches Starship in Second Attempt Advancing HeavyLift Capabilities Spotify Shares Surge 13 on AI Deal with Universal Music and LongTerm Revenue Guidance FBRX Q1 2026 Earnings Narrower Loss But Clinical Path Remains Uncertain